Trial
NCT02412631
Addressing Post Cessation Weight Gain
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Obesity
Intervention
lorcaserin
Why stopped
Lorcaserin removed from market
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-10